CNBC's Rick Santelli discusses the latest action in the bond market, and the U.S. dollar.
Glenview Capital wants to replace the HMA board with eight new nominees, reports CNBC's David Faber.
Check out which companies are making headlines before the bell:
Jim Cramer explains why he is not ready to "throw out" Walgreens and wonders if Rite Aid "is coming back from the dead."
The "Squawk on the Street" news team reports on today's top business headlines, including a look at a possible bounce back at the open, China's credit crunch and the play on Lennar's earnings beat.
Don't start your trading day without finding out what CNBC's Jim Cramer is watching ahead of the opening bell.
Marc Faber, editor of The Gloom, Boom & Doom Report, sees short-term opportunity for stocks but long-term drops.
Julia Bonafede, Wilshire Consulting president, weighs in on the staggering percentage of corporate pension plans which are underfunded.
Joseph Sullivan, Legg Mason CEO, shares his turnaround strategy of returning to the company's model and seek out acquisitions in alternatives and non-U.S. companies.
Jeremy Siegel, Wharton School finance professor, shares his views on what's prompting the sell-off as interest rates return to more normal levels.
Market veterans Marc Faber and Jim O'Neill — known as Dr. Doom and Mr. BRIC respectively — posted opposite views when asked if the Chinese liquidity crunch was real.
Lee Partridge, Salient Partners, and Mark Okada, Highland Capital, share their top defensive and offensive picks amid market volatility.
Richard Steinberg, Steinberg Global Asset Management, explains why he thinks the market sell-off is propelled by investor anxiety and psychological damage from 2008.
CNBC's Louisa Bojesen reports on all the market moving events from Europe, as stocks recover some of the previous day's sharp losses prompted by fears of a credit squeeze in China and potential "tapering" by the U.S. Fed.
Global stock markets may be in the middle of a correction, but Peter Oppenheimer, Goldman Sachs' European equities strategist told CNBC that equities will continue to rally.
WebMD Health has pulled back after a strong earnings report last month, and the bulls are getting long.
Charles Beazley, CEO of Nikko Asset Management, talks about how the tapering discussion has been received in Japan and how retail investors have not changed their long term thinking.
John Studzinski, senior managing director at Blackstone, explains Chinese companies' international investment strategy and why the new government is "a real class act".
Mebane Faber, Chief Investment Officer of Cambria Investment Management finds U.S. stocks expensive. He says other equity markets are cheap including those in Europe.
As the PBOC acts forcefully to tame abuse of easy liquidity, Michael Kurtz, Global Head of Equity Strategy at Nomura discusses the merits and pitfalls of investing in China.